Evidence map›Paper›PMID 40217397›Full record

ArticleActa epileptologica2023

Adult-onset hypothalamic hamartoma: origin of epilepsy?

Wenjie Han, Che Jiang, Zijuan Qi, Wei Xiang, Jian Lin, Youtian Zhou, Zhensheng Li, Bingmei Deng

Abstract read
In one paragraph

Article in Acta epileptologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenjie Han *Department of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China.
Che Jiang *Department of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China.
Zijuan QiDepartment of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China.
Wei XiangDepartment of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China.
Jian LinDepartment of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China.
Youtian ZhouDepartment of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China.
Zhensheng LiDepartment of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China. lizhensheng83@hotmail.com.
Bingmei DengDepartment of Neurology, General Hospital of Southern Theater Command, Guangzhou, 510010, China. bingmeid@163.com.ORCID http://orcid.org/0000-0002-1201-3197

Funding

Foundation of Medical Science and Technology of Guangdong A2022402
6 · The paper itself

Abstract

backgroundHypothalamic hamartoma (HH) is a congenital non-progressive lesion of hypothalamus during fetal development. Mass-like lesions in different anatomical locations often develop a variously disabling course presenting with cognitive decline, psychiatric symptoms, as well as multiple seizure types. As a rare disease, HH is relatively common in infants and children, but it is extremely rare in adults. CASE PRESENTATION: We reported a case of adult-onset hypothalamic hamartoma, and summarized and analyzed relevant reports and studies of HH worldwide. The patient had clinical manifestations characterized by multiple seizure forms. After stereotactic radiofrequency thermocoagulation and drug treatment, the condition was effectively controlled. The patient was followed up till October 2022, with no recurrence of seizures.

conclusionsEpilepsy caused by HH can resemble that of temporal lobe seizures, as HH forms a complex epileptogenic network with other regions of the brain through anatomical and functional connections. Early treatment of HH can provide better control of the symptoms of epilepsy, and patients with longer disease courses may have more complications.

Indexed as

Adult-onsetEpileptogenic networksGelastic seizureHypothalamic hamartomaStereotactic radiofrequency thermocoagulation

Identifiers

PMID40217397
PMCPMC11960393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.